Bengesa v. Immunomedics, Inc

Court

District Court, S.D. New York (S.D.N.Y.)
Official Court Website →

Assigned judge

Valerie E. Caproni · 1,853 cases in index

Docket number

1:20-cv-08227

Cause

28:1331sv Fed. Question: Securities Violation
28 U.S.C. § 1331sv

Nature of suit

850 Securities/Commodities
Alleged violations of federal securities or commodities laws.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

10/02/2020

Date terminated

11/16/2020

13,858 Securities / Commodities cases in this court are indexed here.

Parties

• plaintiff · Bengesa
• defendant · Immunomedics, Inc · 26 cases

Part of a Larger Litigation Pattern

This is one of 27 Securities / Commodities cases in our index naming IMMUNOMEDICS, INC — a possible mass-tort or coordinated-litigation cluster.

• Thomas v. Immunomedics, Inc
  District Court, D. New JerseyFiled 10/09/2020
• Palmisano v. Immunomedics, Inc
  District Court, S.D. New YorkFiled 10/07/2020
• Peterson v. Immunomedics, Inc
  District Court, D. New JerseyFiled 10/01/2020
• Kent v. Immunomedics, Inc
  District Court, D. DelawareFiled 09/29/2020
• Wang v. Immunomedics, Inc
  District Court, D. New JerseyFiled 09/25/2020
• Choi v. Immunomedics, Inc
  District Court, D. New JerseyFiled 02/08/2019

About Securities / Commodities Lawsuits

Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

Frequently Asked Questions

What is Bengesa v. Immunomedics, Inc?

Bengesa v. Immunomedics, Inc is a federal securities / commodities lawsuit filed on 10/02/2020 in the District Court, S.D. New York. The case was terminated on 11/16/2020. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What type of case is this?

It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.

What court is the case in?

The case is in the District Court, S.D. New York, docket number 1:20-cv-08227.

When was the case filed?

Bengesa v. Immunomedics, Inc was filed on 10/02/2020. It was terminated on 11/16/2020.

What law is the case brought under?

The docket lists the cause as 28 U.S.C. § 1331sv.